Why Investing in the Future of Clinical Trials is Smart Business

<p>Devora Torrence is a highly experienced Clinical Research Professional who boasts 17 years of experience, most of which is at the site management organizational level. Devora began her clinical research career in 2003 at the CRO, PPD, in Austin, TX as a project manager for their phase 1 clinical trial division. From there, Devora founded Centex Studies in 2006 (acquired by Headlands Research in 2019) and throughout the years, expanded her business model across five sites from the ground up.<span class= "Apple-converted-space"> </span></p> <p>During her tenure at Centex Studies, she operated as the Clinical Operations President and CEO within the multisite organization. Most impressively, she was able to change the way that her organization conducted clinical research when they were faced with the pandemic. The sites utilized a 100% electronic source system that housed regulatory, source, recruitment, and finance, and they were always on the lookout for the latest innovation to improve their efficiency. During this time, more than 1000 patients were vaccinated or treated for COVID-19 between her sites. Devora has experience in all phases of Clinical Trials and across many therapeutic areas (COVID-19 Vaccine and Treatment, Type II Diabetes, Non-Alcoholic Steatohepatitis, Hypogonadism, Asthma, etc.). As the first site network acquired by the private equity, Headlands Research, Devora had the honor of establishing the multisite networks SOPs. She also had the responsibility of forecasting clinical trial revenue to increase the company’s EBITDA and managing the organization’s operational budget.<span class= "Apple-converted-space"> </span></p> <p>Devora’s leadership skills, innovation, and dedication have been the keys to her successful career. Centex Studies was founded and started with two people and within 15 years, grew to 100+ people across two states. She has developed a rapport with physicians across North America and gained a referral network that was key to her site’s recruitment efforts. Today, Devora is